Special Issues

Special Issue Title: Precision Medicine for Gynecologic Malignancies

· Print Special Issue Flyer

· Deadline for manuscript submissions: 25 April 2022


Special Issue Editor

Guest Editor


Dr. Masayuki Sekine

Department of Obstetrics and Gynecology, Graduate School of medical and Dental Sciences, Niigata University,  Niigata, Japan

Website 

Interests: Hereditary breast and ovarian cancer; Gynecological oncology; HPV (vaccine); Hereditary tumor; BRCA1/2


Special Issue Information

Dear Colleagues,

In gynecologic cancer, the introduction of molecular-targeted drugs was delayed compared to other areas, however, major changes have occurred in both research and clinical practice in the gynecologic area. To classify the detailed characteristics of tumors, the classification of subgroups based on genomic analysis has become the main evidence in deciding personal treatment, replacing the traditional pathological classification. The approval of PARP inhibitor, Immune checkpoint inhibitor, and Angiogenesis inhibitor, has been changing the treatment of gynecologic malignancies.
Many clinical trials have been conducted on the combination of conventional chemotherapy and molecular-targeted drugs, or the combination of several molecular-targeted drugs. Under such circumstances, we would like to widely call for various manuscripts related to “Precision Medicine for Gynecologic Malignancies” in both research and clinical fields.


Dr. Masayuki Sekine

Guest Editor

 

Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1900. Submitted papers should be well formatted and use good English.


Keywords

Genome medicine; Gynaecological oncology; PARP inhibitor; Immune checkpoint inhibitor; Angiogenesis inhibitor; Chemotherapy; Molecular-targeted drugs


Share This Special Issue

     


Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 42, Issue 5